Endocrine Society Recommends Investing in Research on Gender-Affirming Hormone Therapy

July 15, 2024

Submitted by the Endocrine Society in response to The National Institutes of Health (NIH) Request for Information (RFI) on NIH-Wide Strategic Plan for Sexual and Gender Minority (SGM) Health Research (NOT-OD-24-122)

The highest priority needs, and emerging areas of opportunity related to SGM health research at NIH.

"The Endocrine Society recognizes the progress made under the current version of the Strategic Plan to Advance Research on the Health and Well-being of Sexual and Gender Minorities and many of the current scientific themes are still relevant and require additional research.  For instance, chronic disease and comorbidities remain critical drivers of poor overall health in SGM populations and longitudinal studies with registries of transgender individuals should be supported to collect better data on outcomes. We recommend that the following research opportunities be incorporated into the plan:"

arrow Read the Full Letter

Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.